Cronos Group Inc. (CRON.TO)
| Previous Close | 4.2600 |
| Open | 4.2200 |
| Bid | 4.2700 x 0 |
| Ask | 4.2800 x 0 |
| Day's Range | 4.1700 - 4.5000 |
| 52 Week Range | 3.6500 - 11.3700 |
| Volume | |
| Avg. Volume | 358,166 |
| Market Cap | 1.591B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5180 |
| Earnings Date | Feb 24, 2022 - Feb 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.11 |
- The Motley Fool
Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?
Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance. The post Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance? appeared first on The Motley Fool Canada.
- GlobeNewswire
Cronos Group Inc. Announces Conference Participation for May 2022
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Office, will speak at two upcoming conferences: Canaccord Genuity's 6th Annual Cannabis Conference (virtual) on Wednesday, May 11, 2022 at 1:30 p.m. ET. BMO’s 17th Annual Global Farm to Market Conference on Thursday, May 19, 2022 at 2:00 p.m. ET. Webcasts wi
- Baystreet
Stocks in play: Cronos Group Inc.
Today announced its 2022 first-quarter business results. All numbers are in U.S. dollars. Net revenue ...
